Victoza Prescription in Fort Worth at DFWPMA

Looking for a Victoza prescription in Fort Worth, Texas? Victoza (liraglutide) is a prescription GLP-1 medication used to treat type 2 diabetes. It requires careful medical evaluation because inappropriate prescribing or inadequate monitoring can lead to serious health complications.

At DFW Physicians Medical Associates (DFWPMA), our endocrinology, internal medicine, and family medicine physicians conduct comprehensive evaluations of diabetes, metabolic health, medical history, and treatment risks to determine if Victoza is appropriate for you.

DFWPMA offers Victoza prescription evaluations in Fort Worth and can prescribe Victoza to eligible patients when medically appropriate. Victoza is FDA-approved to improve blood sugar control in adults and children aged 10 years and older with type 2 diabetes. It is also approved to reduce the risk of major cardiovascular events in adults with type 2 diabetes and established cardiovascular disease.

Book an appointment online or call (903) 957-0082 to contact our Fort Worth location.

Address: 📍 1220 W. Presidio St., Fort Worth, TX 76102
Click here to get directions

We accept many major insurance plans. Not sure if your plan is accepted?

Call (903) 957-0082 and our team can help verify coverage.

Why Choose DFWPMA for a Victoza Prescription in Fort Worth?

DFW Physicians Medical Associates provides Victoza prescription evaluations in Fort Worth through physicians experienced in endocrinology, diabetes care, metabolic disorders, and chronic disease management. Our multispecialty approach supports individualized diabetes treatment and ongoing medical supervision.

Patients seeking a Victoza prescription at DFWPMA can benefit from:

  • Experienced Medical Providers: Access to endocrinology, internal medicine, and family medicine physicians experienced in diabetes management, metabolic health, and medication evaluations.
  • Comprehensive Eligibility Assessment: Evaluation of diabetes status, medical history, current medications, and potential contraindications before prescribing Victoza.
  • Diabetes and Metabolic Health Evaluation: Assessment of blood glucose, hemoglobin A1c, kidney function, and other relevant metabolic indicators.
  • Individualized Prescription Decisions: Treatment recommendations based on diabetes management goals, medication history, clinical risks, and overall health.
  • Medication Safety Screening: Review of contraindications and precautions involving thyroid cancer history, pancreatitis, gastrointestinal disorders, gallbladder disease, and other relevant conditions.
  • Daily Injection Management: Guidance on Victoza administration, dose adjustments, injection technique, and medication tolerance.
  • Long-Term Diabetes Management: Ongoing evaluation of blood sugar control, cardiovascular risk factors, treatment effectiveness, and chronic disease management.
  • Coordinated Multispecialty Care: Access to additional medical and behavioral health services when patients require comprehensive support for diabetes-related health concerns.

Victoza is not appropriate for every patient with type 2 diabetes. Prescribing decisions require evaluating glycemic control, cardiovascular risk factors, potential adverse effects, contraindications, and alternative diabetes medications.

At DFWPMA, comprehensive medical evaluation and individualized treatment planning are central to determining whether Victoza is an appropriate diabetes medication.

Schedule an appointment with DFWPMA Fort Worth to discuss Victoza prescription eligibility and your diabetes treatment options.

Meet Our Victoza Prescription Providers in Fort Worth

DFWPMA Fort Worth offers Victoza prescription evaluations through physicians whose clinical expertise includes endocrinology, internal medicine, family medicine, diabetes care, and metabolic disorders. These providers can assess medical eligibility and determine whether Victoza is appropriate.

Gitana Staskus, MD – Endocrinology

Dr. Gitana Staskus is a board-certified endocrinologist with more than 20 years of clinical experience diagnosing and treating endocrine and metabolic disorders in adults and older adults.

Her expertise includes type 1 and type 2 diabetes, gestational diabetes, weight management, metabolic disorders, thyroid conditions, hormone disorders, and osteoporosis. Dr. Staskus emphasizes individualized treatment planning, patient education, and long-term management of endocrine conditions.

Her specialized background in diabetes and metabolic health is particularly relevant for patients seeking Victoza prescription evaluations, including individuals with type 2 diabetes and additional metabolic conditions.

Soheila Hesami, MD – Internal Medicine

Dr. Soheila Hesami is a board-certified internal medicine physician with more than 20 years of experience providing comprehensive healthcare for adults and older adults.

Her clinical expertise includes diabetes care, hypertension, high cholesterol, chronic disease management, medication management, preventive medicine, and comprehensive health evaluations.

Dr. Hesami’s experience managing diabetes and related chronic medical conditions supports Victoza prescription evaluations, including assessment of blood sugar control, medication safety, and individualized treatment planning.

Anisha Zaman, MD – Family Medicine

Dr. Anisha Zaman is a family medicine physician providing comprehensive outpatient care, preventive medicine, and chronic disease management in Fort Worth.

Her clinical background includes diabetes management, hypertension treatment, patient education, preventive healthcare, and lifestyle-focused medical care. She completed her family medicine residency at the University of Arkansas for Medical Sciences.

Dr. Zaman’s experience in diabetes care and chronic disease management supports medical evaluations for patients considering Victoza, including assessment of glycemic control, treatment eligibility, and long-term health goals.

Michael Huang, MD – Family Medicine

Dr. Michael Huang is a board-certified family medicine physician with more than 13 years of clinical experience providing preventive healthcare, chronic disease management, and comprehensive medical care.

His expertise includes diabetes management, hypertension, preventive medicine, treatment of acute illnesses, and long-term management of chronic health conditions. Dr. Huang provides care in English and Spanish.

His experience managing diabetes and related metabolic conditions is relevant to Victoza prescription evaluations, medication monitoring, and comprehensive diabetes management.

Book an appointment online to inquire about Victoza prescription evaluations with DFWPMA’s medical providers in Fort Worth.

What Can a Victoza Prescription in Fort Worth Help With?

Victoza (liraglutide) is a once-daily injectable GLP-1 receptor agonist approved to improve blood sugar control in patients aged 10 years and older with type 2 diabetes. It also reduces the risk of major cardiovascular events in adults with type 2 diabetes and established cardiovascular disease.

At DFWPMA Fort Worth, Victoza prescription evaluations address:

  • Type 2 Diabetes Management: Improving blood sugar control in eligible patients with type 2 diabetes.
  • Elevated Hemoglobin A1c: Lowering A1c levels that exceed individualized diabetes treatment goals.
  • Cardiovascular Risk Reduction: Reducing major cardiovascular events in adults with type 2 diabetes and established cardiovascular disease.
  • Blood Sugar Regulation: Improving glucose control through GLP-1 receptor activation.
  • Pediatric Type 2 Diabetes: Improving glycemic control in eligible children aged 10 years and older.
  • Complex Diabetes Treatment Needs: Evaluating Victoza when existing diabetes medications provide insufficient glycemic control.
  • Diabetes With Additional Metabolic Conditions: Managing type 2 diabetes alongside obesity, hypertension, or high cholesterol.

Victoza activates GLP-1 receptors, increasing glucose-dependent insulin secretion, reducing glucagon secretion, and slowing gastric emptying. These effects help improve blood sugar control in patients with type 2 diabetes.

The American Academy of Family Physicians recognizes GLP-1 receptor agonists as established noninsulin treatment options for type 2 diabetes, with medication selection based on effectiveness, safety, and individual patient needs.

Source: American Academy of Family Physicians – Management of Type 2 Diabetes Mellitus With Noninsulin Pharmacotherapy

Victoza is not indicated for type 1 diabetes and is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or MEN2. Important risks include pancreatitis, severe gastrointestinal reactions, dehydration-related kidney injury, gallbladder disease, and hypoglycemia when combined with certain diabetes medications.

Although some patients experience weight loss while taking Victoza, it is not specifically approved for chronic weight management. Saxenda contains the same active ingredient, liraglutide, but is approved for weight management in eligible patients.

Source: American College of Physicians – Pharmacologic Treatments for Overweight and Obesity

Schedule an appointment to discuss Victoza prescription eligibility at DFWPMA Fort Worth.

What Victoza Prescription Services Are Available at DFWPMA Fort Worth?

DFWPMA Fort Worth provides Victoza prescription evaluations, diabetes and metabolic testing, medication safety reviews, treatment planning, and ongoing monitoring through endocrinology, internal medicine, and family medicine providers.

Our Victoza prescription services include:

  • Initial Victoza Prescription Evaluation: Reviewing medical history, diabetes status, and treatment eligibility.
  • Diabetes and Metabolic Testing: Checking A1c, blood glucose, kidney function, and relevant metabolic markers.
  • Medication and Contraindication Review: Identifying medication interactions, contraindications, and potential health risks.
  • Victoza Prescription and Treatment Planning: Prescribing Victoza when medically appropriate and establishing diabetes management goals.
  • Starting Dose and Titration: Adjusting dosage according to prescribing guidance, treatment response, and tolerance.
  • Side Effect Monitoring: Assessing gastrointestinal symptoms, dehydration, and other adverse reactions.
  • Blood Sugar and Treatment Response Monitoring: Tracking glucose control, A1c changes, and medication effectiveness.
  • Long-Term Diabetes and Metabolic Care: Managing diabetes, cardiovascular risk factors, and related chronic conditions.
  • Alternative Diabetes Medication Evaluation: Considering other approved medications when Victoza is unsuitable.
  • Follow-Up and Coordinated Care: Providing continued medical supervision and specialty referrals when needed.

Victoza typically starts at 0.6 mg once daily for one week, followed by 1.2 mg daily. If additional blood sugar control is needed, the dose may increase to 1.8 mg daily after at least another week. The initial adult dose helps reduce gastrointestinal side effects rather than providing full glycemic control.

Common side effects include nausea, vomiting, diarrhea, constipation, and abdominal discomfort. Severe abdominal pain, significant dehydration, or allergic reactions require prompt medical attention.

The American Academy of Family Physicians emphasizes individualized diabetes medication selection based on effectiveness, safety, cardiovascular risk, and patient treatment goals.

Source: American Academy of Family Physicians – Management of Type 2 Diabetes Mellitus With Noninsulin Pharmacotherapy

Not every patient qualifies for Victoza. A medical evaluation determines whether the medication or an alternative diabetes treatment is appropriate. Victoza should not be combined with other liraglutide-containing medications, including Saxenda.

Looking for a Victoza prescription in Fort Worth? Book an appointment or call (903) 957-0082 to schedule your evaluation at DFWPMA.